Clinical Trial Update: Asunercept in Patients With Severe COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial update for asunercept in patients with COVID-19–related pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• asunercept (asunercept)

Snippet

Sponsor: Apogenix AG | Conditions: COVID-19 Induced Pneumonia, Covid19 | Phase 2 | Status: COMPLETED